'KKR Nears Deal To Buy Stake In Cotiviti From Veritas Capital In A Deal That Would Value The Healthcare-Technology Company At Around $11B' - WSJ
Portfolio Pulse from Benzinga Newsdesk
Private-equity firm Veritas Capital is nearing a deal to sell a stake in healthcare-technology company Cotiviti to KKR, valuing Cotiviti at approximately $11 billion, as reported by the Wall Street Journal.
December 11, 2023 | 9:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
KKR is in the process of acquiring a stake in Cotiviti from Veritas Capital, in a deal valuing the latter at $11 billion.
The acquisition of a stake in Cotiviti by KKR is likely to be viewed positively by investors as it represents strategic growth in the healthcare-technology sector. The valuation of $11 billion indicates a significant investment and potential for future returns. This news could lead to a short-term increase in KKR's stock price as the market reacts to the expansion of KKR's portfolio.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80